Finance

Beta
Lists
8WK:FRA
Abera Bioscience AB
€0.59
0.00%
(0.00) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8WK...
Open
€0.60
High
€0.60
Low
€0.59
Avg. vol.
4.00
Volume
0.00
52-wk high
€0.84
52-wk low
€0.44
No. of employees
6
Open
€0.60
High
€0.60
Low
€0.59
Avg. vol.
4.00
Volume
0.00
52-wk high
€0.84
52-wk low
€0.44
No. of employees
6
News stories
From sources across the web
About Abera Bioscience AB
CEOMaria Alriksson
Employees6
Founded2012
Headquarters-
SectorBiotechnology
Websiteaberabio.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.30M
4.92M
-902.00K
3.55M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.07M
5.70M
7.85M
9.30M
Operating expense
5.14M
5.79M
7.96M
9.39M
Total operating expenses
5.14M
5.79M
7.96M
9.39M
Operating income
-843.00K
-867.00K
-8.87M
-5.83M
Other non operating income
-
-2.00K
1.00K
-
EBT including unusual items
-833.00K
-835.00K
-8.80M
-5.80M
EBT excluding unusual items
-833.00K
-835.00K
-8.80M
-5.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
27.00K
42.00K
49.00K
25.00K
Net income
-833.00K
-835.00K
-8.80M
-5.80M
Net profit margin
-19.39%
-16.97%
975.28%
-163.13%
Earnings per share
-
-
-
-
Interest and investment income
10.00K
34.00K
68.00K
40.00K
Interest expense
-
-
-
-2.00K
Net interest expenses
10.00K
34.00K
68.00K
38.00K
Depreciation and amortization charges
42.00K
45.00K
62.00K
63.00K
EBITDA
-801.00K
-822.00K
-8.80M
-5.77M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer